Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 10/2018

01-10-2018 | Letter to the Editor

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis

Authors: Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Tait D. Shanafelt

Published in: Annals of Hematology | Issue 10/2018

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
International CLL-IPI working group (2016) An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol 17(6):779–790CrossRef
2.
Gentile M, Shanafelt TD, Rossi D, Laurenti L, Mauro FR, Molica S, Cutrona G, Uccello G, Campanelli M, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foa R, Morabito F (2016) Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients. Blood 128(16):2093–2095CrossRef
3.
da Cunha-Bang C, Christiansen I, Niemann CU (2016) The CLL-IPI applied in a population-based cohort. Blood 128(17):2181–2183CrossRef
4.
Goede V, Bahlo J, Kutsch N et al (2016) Evaluation of the International prognostic index for chronic lymphocytic leukemia (CLL-IPI) in elderly patients with comorbidities: analysis of the CLL11 study population. Blood 128:4401
5.
Ferrer Lores B, Navarro Cubells B, Serrano Alcala A et al (2016) Prognostic impact of the new CLL-IPI Index in a single center CLL Spanish cohort. Blood 128:2019
6.
Delgado J, Doubek M, Baumann T, Kotaskova J, Molica S, Mozas P, Rivas-Delgado A, Morabito F, Pospisilova S, Montserrat E (2017) Chronic lymphocytic leukemia: a prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. Am J Hematol 92(4):375–380CrossRef
7.
Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, Guardalben E, Liberatore C, Faraci D, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A (2017) In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood 129(26):3495–3498CrossRef
8.
Reda G, Cassin R, Fattizzo B, Giannarelli D, Mattiello V, Barcellini W, Cortelezzi A (2017) Chronic lymphocytic leukemia and prognostic models: a bridge between clinical and biological markers. Am J Hematol 92(7):E135–E137CrossRef
9.
Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, di Renzo N, di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F (2016) The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: independent validation in a prospective cohort of early stage patients. Am J Hematol 91:1090–1095CrossRef
10.
Soumerai JD, Barrientos JC, Hallek M et al (2016) An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies. J Clin Oncol 34(15_suppl):7513CrossRef
11.
Brander DM, Rhodes J, Pagel JM et al (2017) Applicability of the chronic lymphocytic leukemia (CLL)-IPI on patients treated with front-line ibrutinib in the real world: the case for new prognostic models. Blood 130:1719
12.
Soumerai JD, Ni A, Darif M et al (2017) A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care. Blood 130:4303
13.
Molica S, Giannarelli D, Mirabelli R, Levato L, Kay NE, Shanafelt TD (2018) Chronic lymphocytic leukemia international prognostic index (CLL-IPI): a systematic review and meta-analysis. Blood 131(3):365–368CrossRef
Metadata
Title
Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis
Authors
Stefano Molica
Diana Giannarelli
Rosanna Mirabelli
Luciano Levato
Tait D. Shanafelt
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 10/2018
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3350-5

Other articles of this Issue 10/2018

Annals of Hematology 10/2018 Go to the issue

Original Article

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)

Original Article

Reduced-dose EPOCH-R chemotherapy for elderly patients with advanced stage diffuse large B cell lymphoma

Original Article

Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials

Original Article

Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia

Original Article

Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales

Original Article

Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits